These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 38335663)
1. Generation of an induced pluripotent stem cell line (LVPEIi002-A) with heterozygous RB1 mutation using peri-orbital fat derived mesenchymal cells of a patient with inherited retinoblastoma. Agrawal T; Maddileti S; Verma A; Kaliki S; Mariappan I Stem Cell Res; 2024 Apr; 76():103329. PubMed ID: 38335663 [TBL] [Abstract][Full Text] [Related]
2. Generation and characterization of three CRISPR/Cas9 edited RB1 null hiPSC lines for retinoblastoma disease modelling. Agrawal T; Maddileti S; Mariappan I Stem Cell Res; 2024 Apr; 76():103373. PubMed ID: 38452707 [TBL] [Abstract][Full Text] [Related]
3. Generation of induced pluripotent stem cells (iPSCs) from a retinoblastoma patient carrying a c.2663G>A mutation in RB1 gene. Zeng S; Liu L; Ouyang Q; Zhao Y; Lin G; Hu L; Li W Stem Cell Res; 2016 Sep; 17(2):208-211. PubMed ID: 27879208 [TBL] [Abstract][Full Text] [Related]
4. Characterization of human-induced pluripotent stem cells carrying homozygous RB1 gene deletion. Deng X; Iwagawa T; Fukushima M; Watanabe S Genes Cells; 2020 Jul; 25(7):510-517. PubMed ID: 32277725 [TBL] [Abstract][Full Text] [Related]
5. Heterozygous RB1 mutation enhanced ATP production in human iPSC-derived retinal organoids. Vincent A; Krishnakumar S; Parameswaran S Mol Biol Rep; 2024 May; 51(1):606. PubMed ID: 38704498 [TBL] [Abstract][Full Text] [Related]
6. Mutational screening of germline Nguyen HH; Nguyen HTT; Vu NP; Le QT; Pham CM; Huyen TT; Manh H; Pham HLB; Nguyen TD; Le HTT; Van Nong H Mol Vis; 2018; 24():231-238. PubMed ID: 29568217 [TBL] [Abstract][Full Text] [Related]
7. Generation of a human induced pluripotent stem cell line (VRFi001-A) from orbital adipose tissue of a bilateral retinoblastoma patient with heterozygous RB1 gene deletion. Vincent A; Khetan V; Rishi P; Suganeswari G; Krishnakumar S; Krishnan UM; Parameswaran S Stem Cell Res; 2018 May; 29():42-45. PubMed ID: 29579639 [TBL] [Abstract][Full Text] [Related]
8. Spectrum of mutations in the Kiet NC; Khuong LT; Minh DD; ; Quan NHM; Xinh PT; Trang NNC; Luan NT; Khai NM; Vu HA Mol Vis; 2019; 25():215-221. PubMed ID: 30996590 [TBL] [Abstract][Full Text] [Related]
9. Heterozygous retinoblastoma gene mutation compromises in vitro osteogenesis of adipose mesenchymal stem cells - a temporal gene expression study. Vincent A; Natarajan V; Khetan V; Krishnakumar S; Parameswaran S Exp Cell Res; 2020 Nov; 396(1):112263. PubMed ID: 32890459 [TBL] [Abstract][Full Text] [Related]
10. Generation and characterization of two induced pluripotent stem cell lines from conjunctiva of a retinoblastoma patient. Xu P; Guo F; Xiao W; Wang Y; Ye K; Mao Y; Zhong X Stem Cell Res; 2023 Oct; 72():103200. PubMed ID: 37708614 [TBL] [Abstract][Full Text] [Related]
11. Biallelic and monoallelic deletion of the RB1 promoter in six isogenic clonal H9 hESC lines. Döpper H; Horstmann M; Menges J; Bozet M; Kanber D; Steenpass L Stem Cell Res; 2020 May; 45():101779. PubMed ID: 32268247 [TBL] [Abstract][Full Text] [Related]
12. Role of RB1 in human embryonic stem cell-derived retinal organoids. Zheng C; Schneider JW; Hsieh J Dev Biol; 2020 Jun; 462(2):197-207. PubMed ID: 32197890 [TBL] [Abstract][Full Text] [Related]
13. Next-Generation Sequencing of Retinoblastoma Identifies Pathogenic Alterations beyond RB1 Inactivation That Correlate with Aggressive Histopathologic Features. Afshar AR; Pekmezci M; Bloomer MM; Cadenas NJ; Stevers M; Banerjee A; Roy R; Olshen AB; Van Ziffle J; Onodera C; Devine WP; Grenert JP; Bastian BC; Solomon DA; Damato BE Ophthalmology; 2020 Jun; 127(6):804-813. PubMed ID: 32139107 [TBL] [Abstract][Full Text] [Related]
14. Spectrum of germline mutations in RB1 in Chinese patients with retinoblastoma: Application of targeted next-generation sequencing. Zou Y; Li J; Hua P; Liang T; Ji X; Zhao P Mol Vis; 2021; 27():1-16. PubMed ID: 33456302 [TBL] [Abstract][Full Text] [Related]
16. Fang X; Chen J; Wang Y; Zhao M; Zhang X; Yang L; Ni X; Zhao J; Gallie BL Ophthalmic Genet; 2021 Oct; 42(5):593-599. PubMed ID: 34190019 [No Abstract] [Full Text] [Related]
17. Clinical characteristics and germline mutation spectrum of RB1 in Chinese patients with retinoblastoma: A dual-center study of 145 patients. Chai P; Luo Y; Yu J; Li Y; Yang J; Zhuang A; Fan J; Han M; Jia R Exp Eye Res; 2021 Apr; 205():108456. PubMed ID: 33493472 [TBL] [Abstract][Full Text] [Related]
18. Hereditary retinoblastoma iPSC model reveals aberrant spliceosome function driving bone malignancies. Tu J; Huo Z; Yu Y; Zhu D; Xu A; Huang MF; Hu R; Wang R; Gingold JA; Chen YH; Tsai KL; Forcioli-Conti NR; Huang SXL; Webb TR; Su J; Bazer DA; Jia P; Yustein JT; Wang LL; Hung MC; Zhao Z; Huff CD; Shen J; Zhao R; Lee DF Proc Natl Acad Sci U S A; 2022 Apr; 119(16):e2117857119. PubMed ID: 35412907 [TBL] [Abstract][Full Text] [Related]
19. Modeling Developmental and Tumorigenic Aspects of Trilateral Retinoblastoma via Human Embryonic Stem Cells. Avior Y; Lezmi E; Yanuka D; Benvenisty N Stem Cell Reports; 2017 May; 8(5):1354-1365. PubMed ID: 28392220 [TBL] [Abstract][Full Text] [Related]
20. Novel insights into RB1 mutation. Yao Y; Gu X; Xu X; Ge S; Jia R Cancer Lett; 2022 Oct; 547():215870. PubMed ID: 35964818 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]